We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$110B
AUM Growth
+$10.8B
Cap. Flow
+$4.52B
Cap. Flow %
4.11%
Top 10 Hldgs %
23.63%
Holding
4,320
New
332
Increased
2,194
Reduced
1,423
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 14.49%
2 Financials 8.91%
3 Healthcare 8.14%
4 Industrials 6.57%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGEN icon
3801
Precigen
PGEN
$2.51B
$112K ﹤0.01%
17,209
+800
+5% +$5.59K
IPOF
3802
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$112K ﹤0.01%
11,010
-8,922
-45% -$92K
APTS
3803
DELISTED
Preferred Apartment Communities, Inc.
APTS
$112K ﹤0.01%
11,461
+66
+0.6% +$669
CANG
3804
Cango Inc
CANG
$67.7M
$111K ﹤0.01%
1,980
+150
+8% +$9.15K
CMU
3805
DELISTED
MFS High Yield Municipal Trust
CMU
$111K ﹤0.01%
23,415
DNTH icon
3806
Dianthus Therapeutics
DNTH
$6.25B
$110K ﹤0.01%
700
-113
-14% -$20.8K
CTAC.U
3807
DELISTED
Cerberus Telecom Acquisition Corp. Units, each consisting of one Class A ordinary share and one-thir
CTAC.U
$110K ﹤0.01%
10,605
-1,810
-15% -$18.7K
SPY icon
3808
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$107K ﹤0.01%
34,100
-14,400
-30% -$6.01M
MOTS
3809
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$106K ﹤0.01%
+340
New +$111K
PHK
3810
PIMCO High Income Fund
PHK
$878M
$105K ﹤0.01%
15,329
+103
+0.7% +$706
CNDT icon
3811
Conduent
CNDT
$242M
$104K ﹤0.01%
13,888
-500
-3% -$3.65K
III icon
3812
Information Services Group
III
$251M
$104K ﹤0.01%
+17,804
New +$92.2K
SCYX icon
3813
SCYNEXIS
SCYX
$51.2M
$104K ﹤0.01%
1,774
+300
+20% +$18.9K
BNGO icon
3814
Bionano Genomics
BNGO
$13.3M
$102K ﹤0.01%
23
-8
-26% -$31.6K
NUVB icon
3815
Nuvation Bio
NUVB
$2.32B
$102K ﹤0.01%
+10,960
New +$125K
CLAR icon
3816
CALL
Clarus
CLAR
$145M
$101K ﹤0.01%
+31,700
New +$676K
CTG
3817
DELISTED
Computer Task Group, Inc.
CTG
$101K ﹤0.01%
+10,470
New +$105K
FPAC
3818
DELISTED
Far Peak Acquisition Corporation
FPAC
$101K ﹤0.01%
10,200
AAOI icon
3819
Applied Optoelectronics
AAOI
$11.2B
$100K ﹤0.01%
11,770
+200
+2% +$1.63K
BABA icon
3820
CALL
Alibaba
BABA
$317B
$98K ﹤0.01%
+27,500
New +$6.11M
PBT
3821
Permian Basin Royalty Trust
PBT
$1.52B
$98K ﹤0.01%
17,350
CHS
3822
DELISTED
Chicos FAS, Inc.
CHS
$98K ﹤0.01%
+14,835
New +$63.9K
ITRG
3823
Integra Resources
ITRG
$535M
$96K ﹤0.01%
13,131
-3,902
-23% -$30.2K
SRGA
3824
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$95K ﹤0.01%
+2,278
New +$117K
XCUR icon
3825
Exicure
XCUR
$8.73M
$94K ﹤0.01%
417

Similar funds

Raymond James & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Raymond James & Associates held 4,320 positions worth $110B, up 11% from $99.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.52B of net new capital in Q2 2021, opening 332 new positions and adding to 2,194 existing holdings. Its largest new stake was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $175M trimmed.

  • Raymond James & Associates's largest Q2 2021 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $290M increase.
  • Raymond James & Associates's biggest Q2 2021 reduction was Amgen, cutting an estimated $175M.
  • Raymond James & Associates fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $19.1M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $110B portfolio in Q2 2021.
  • Raymond James & Associates opened 332 new positions and closed 241 in Q2 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.